Cargando…
A 5-year retrospective cohort study of denosumab induced medication related osteonecrosis of the jaw in osteoporosis patients
Denosumab has been suggested as a first-line therapy for osteoporotic patients. However, a standardized protocol for the prevention of denosumab induced medication-related osteonecrosis of the jaw (MRONJ) has not yet been established. The purpose of this study was to report denosumab induced MRONJ c...
Autores principales: | Jung, Seoyeon, Kim, Jaeyeon, Park, Jin Hoo, Kim, Ki-Yeol, Kim, Hyung Jun, Park, Wonse |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126865/ https://www.ncbi.nlm.nih.gov/pubmed/35606457 http://dx.doi.org/10.1038/s41598-022-11615-9 |
Ejemplares similares
-
Preventive effect of teriparatide on medication-related osteonecrosis of the jaw in rats
por: Park, Kyeong-Mee, et al.
Publicado: (2023) -
Denosumab and osteonecrosis of the jaw
por: Bower, Robert
Publicado: (2019) -
Osteonecrosis of the jaw and denosumab
por: Goss, Alastair N
Publicado: (2022) -
Medication-related osteonecrosis of the jaw using periodontitis-induced rat before tooth extraction
por: Park, Kyeong-Mee, et al.
Publicado: (2023) -
Denosumab Related Osteonecrosis of Jaw: a Case Report
por: de Sales Lima, Marco Vinícius, et al.
Publicado: (2018)